Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate-risk group.

Adjuvant therapy is optional for some patients with CC-IR; however, chemotherapy can be recommended as adjuvant therapy, particularly for patients with large tumors.